DrugPatentWatch Database Preview
Ironshore Pharms Company Profile
What is the competitive landscape for IRONSHORE PHARMS, and what generic alternatives to IRONSHORE PHARMS drugs are available?
IRONSHORE PHARMS has one approved drug.
There are four US patents protecting IRONSHORE PHARMS drugs.
Summary for Ironshore Pharms
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Ironshore Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-004 | Aug 8, 2018 | RX | Yes | No | 8,927,010 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-001 | Aug 8, 2018 | RX | Yes | No | 9,283,214 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Ironshore Pharms | JORNAY PM | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 209311-005 | Aug 8, 2018 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for Ironshore Pharms
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 8,916,588 | Methods for treatment of attention deficit hyperactivity disorder | ➤ Sign Up |
| 9,289,394 | Compositions for treatment of attention deficit hyperactivity disorder | ➤ Sign Up |
| 9,119,809 | Compositions for treatment of attention deficit hyperactivity disorder | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Ironshore Pharms Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Japan | 2014508812 | ➤ Sign Up |
| Australia | 2018202002 | ➤ Sign Up |
| Portugal | 2688557 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.
